期刊文献+

静脉移植骨髓间充质干细胞联合重组人生长激素对充血性心肌病大鼠心肌和血管组织的修复 被引量:1

Intravenous transplantation of bone marrow mesenchymal stem cells in combination with recombinant human growth hormone repairs myocardium and vascular tissues in rats with congestive cardiomyopathy
暂未订购
导出
摘要 背景:骨髓间充质干细胞静脉移植后,能否归巢至心脏受损部位和分化为心肌样细胞尚无统一定论。目的:探讨重组人生长激素联合骨髓间充质干细胞静脉移植对充血性心肌病大鼠心肌和血管新生的影响。方法:密度梯度离心和贴壁筛选法获得大鼠骨髓间充质干细胞。模型组、细胞移植组、生长激素组、联合组大鼠均在阿霉素诱导下建立心脏衰竭模型。造模后,细胞移植组经静脉注入BrdU标记的骨髓间充质干细胞8×1013L-1;生长激素组皮下注射重组人生长激素2U/(kg·d),连续14d;联合组行骨髓间充质干细胞移植与重组人生长激素注射。4周后取材,BrdU+MHC及BrdU+Actin免疫组化染色确定骨髓间充质干细胞的归巢情况,评价移植细胞向心肌样细胞和血管内皮细胞的分化,苏木精-伊红染色检测血管密度。结果与结论:与细胞移植组比较,联合组BrdU免疫组化阳性率显著升高(P<0.001);BrdU+MHC双染和BrdU+Actin双染后心肌样细胞、血管内皮细胞均显著增多(P<0.001)。与模型组比较,生长激素组、细胞移植组、联合组的总血管密度、微血管密度、毛细血管密度均显著升高(P<0.001),后3组间比较无明显差异(P>0.05)。结果证实骨髓间充质干细胞静脉移植后可归巢到心脏,对充血性心肌病大鼠心肌和血管有明显修复作用,能在损伤处区存活、生长,并向心肌样细胞、血管内皮细胞方向分化,增加损伤处血管密度;生长激素可以改善微环境,加强骨髓间充质干细胞向心肌样细胞、血管内皮细胞的转化率。 BACKGROUND: It is controversial whether bone marrow mesenchymal stem calls can retain in cardiac injured position, or differentiate into cardiomyocytes or not. OBJECTIVE: To study the effects of recombinant human growth hormone and bone marrow mesenchymal stem calls (BMSCs) intravenous transplantation on myocardium and angiogenesis in rats with congestive cardiomyopathy. METHODS: BMSCs were collected from rats by density gradient cantrifugation and adhesive-screening method. Models of cardiac failure were established using adriamycin induction in the model, cell transplantation, growth hormone and combination groups. Following model establishment, cell transplantation group received BrdU-labeled BMSCs (8×1013/L) via vein. Growth hormone group underwent subcutaneous injection of human growth hormone 2 U/kg per day, for 14 consecutive days. Combination group received injection of human growth hormone and BMSC transplantation, At week 4, samples were collected. Immunohistochemical staining for BrdU+MHC and BrdU+Actin was used to determine homing of BMSCs to evaluate the differentiation of transplanted calls into cardiomyocytes and vascular endothelia cells. Hematoxylin-eosin staining was utilized to detect vascular density. RESULTS AND CONCLUSION: Compared with the cell transplantation group, positive rate of Brdu immunohistochemistry was increased in the combination group (P 〈 0.001 ). The number of cardiomyocytes and vascular endothelia calls was significantly increased following Brdu+MHC and Brdu+Actin staining (P 〈 0.001). Compared with the model group, total vascular density, microvessel density and capillary density were significantly increased in the growth hormone, cell transplantation and combinatior groups (P 〈 0.001 ). No significant difference was determined among growth hormone, call transplantation and combination groups (P 〉 0.05). intravenous transplantation of BMSCs could repair cardiomyocytes and vascular endothelial cells by homing into the heart. BMSCs could survive in damaged area and differentiate into cardiomyocytes or vascular endothelial cells and increase the vascular density significantly. Growth hormone could improve microenvironment and raise rates of differentiating into cardiomyocytes or vascular endothelial cells.
作者 姚巍 王凤芝
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2010年第6期1064-1067,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
基金 山西省高校科研开发项目(200811073) 山西医科大学博士科题~~
  • 相关文献

参考文献5

二级参考文献28

  • 1王建安,谢小洁.干细胞移植治疗扩张型心肌病[J].中华心血管病杂志,2006,34(3):200-201. 被引量:9
  • 2Suzuki K,Murtuza B,Suzuki N,et al.Intracoronary infusion of skeletal myoblasts improves cardiac function in doxorubicin-induced heart failure.Circulation,2001,104 12suppl:1213-1217.
  • 3Yoo KJ,Li RK,Weisel RD,et al.Autologous smooth muscle cell transplantation improved heart function in dilated cardiomyopathy.Ann Thorac Surg,2000,20(3):859-865.
  • 4Ishida M,Tomita S,Nakatani T,et al.Bone marrow mononuclear cell transplantation had beneficial effects on doxorubicin-induced cardiomyopathy.Heart Lung Transplant,2004,23 (4):436-445.
  • 5Makine S,Fukuda K,Miyoshi S,et al.Cardiomyocytes can be generated from marrow stromal cells in vitro.J Clin Invest,1999,103:697-705.
  • 6Yang YK,Min JY,Rana JS,et al.VEGF enhances functional improvement of postinfarcted hearts by transplantation of ESC-differentiated cells.J Appl Physiol,2002,93:1140-1151.
  • 7Gould D,Arabum C,Capdevielle M,et al.Angiogenic activity of anterior pituitary tissue and growth hormone on the chick embryochorioal:a novel of GH.Life Sci,1995,56(8):587-594.
  • 8Oberbauer AM,Peng R.Growth hormone and IGF-Ⅰ stimulate cell function in distinct zones of the rat epiphysesl growth plate.Connect Tissue Res,1995,31(3):189-195.
  • 9Smith L,Kopchick J,Chen W,et al.Essential role of growth hormone in ischemia-induced neovascularization retinal.Science,1997,276:1706-1709.
  • 10Molina EJ, Palma J, Gupta D,et al.Improvement in hemodynamic performance, exercise capacity, inflammatory profile, and left ventricular reverse remodeling after intracoronary delivery of mesenchymal stem cells in an experimental model of pressure overload hypertrophy. J Thorac Cardiovasc Surg 2008;135(2):292-299

共引文献48

同被引文献37

  • 1徐瑾,王彬尧,陈颖敏,何奔.经静脉移植骨髓间充质干细胞向扩张性心肌病大鼠心肌趋化的研究[J].心脏杂志,2007,19(3):262-265. 被引量:3
  • 2李杨,陈沅,田杰,邱俊,朱静,张小飞.心肌病大鼠骨髓间充质干细胞移植后差异表达基因cDNA文库的构建[J].中国组织工程研究与临床康复,2007,11(37):7365-7368. 被引量:2
  • 3Kawamura M,Miyagawa S,Miki K,et al.Feasibility,safety,and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model.Circulation.2012;126(11 Suppl 1):S29-37.
  • 4Sousa MG,Paulino-Junior Dj Pascon JP,et al.Cardiac function in dogs with chronic Chagas cardiomyopathy undergoing autologous stem cell transplantation into the coronary arteries.Can Vet J.2011;52(8):869-874.
  • 5Tatsumi K,Otani H,Sato D,et al.Granulocyte-colony stimulating factor increases donor mesenchymal stem cells in bone marrow and their mobilization into peripheral circulation but does not repair dystrophic heart after bone marrow transplantation.Circ J.2008;72(8):1351-1358.
  • 6Chen Yj Liu W,Li W,et al.Autologous bone marrow mesenchymal cell transplantation improves left ventricular function in a rabbit model of dilated cardiomyopathy.Exp Mol Pathol.2010:88(2):311-315.
  • 7Quevedo HC,Hatzistergos KE,Oskouei BNf et al.Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity.Proc Natl Acad Sci U SA.2009;106(33):14022-14027.
  • 8Templin C,Luscher TF,Landmesser U.Cell-based cardiovascular repair and regeneration in acute myocardial infarction and chronic ischemic cardiomyopathy-current status and future developments.Int J Dev Biol.2011;55(4-5):407-417.
  • 9Skou AS,Tranebjaerg L,Jensen Tj et al.Mitochondrial 12S ribosomal RNAA1555G mutation associated with cardiomyopathy and hearing loss following high-dose chemotherapy and repeated aminoglycoside exposure.J Pediatr.2014;164(2):413-415.
  • 10van der Spoel Tl,Vrijsen KR,Koudstaal S,et al.Transendocardial cell injection is not superior to intracoronary infusion in a porcine model of ischaemic cardiomyopathy: a study on delivery efficiency.J Cell Mol Med.2012:16(11):2768-2776.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部